SCYNEXIS
SCYX • NASDAQ • Stock Fundamentals
SCYNEXIS is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David Gonzalez Angulo, with a market cap of $54.1M.
Market Cap$54.1M
Employees29.0
CEODavid Gonzalez Angulo
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
SCYNEXIS FAQ
Common questions about SCYNEXIS
SCYNEXIS (SCYX) has a market capitalization of $54.1M and trades on NASDAQ.
SCYNEXIS has approximately 29 employees.